Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A syringe and ampoule in a clinical setting, symbolizing the launch of a new biosimilar.

May 29, 2026

Samsung Bioepis Launches OPUVIZ Biosimilar in Europe

Samsung Bioepis has introduced OPUVIZ, a new biosimilar in Europe that references the well-known Eylea (aflibercept). This launch represents the fifth biosimilar product from Samsung Bioepis, following a recent introduction of a biosimilar referencing Stelara (ustekinumab) in Japan. The company aims to enhance patient access to ophthalmology treatments with OPUVIZ, as highlighted by Antonio Rito, Vice President and Head of Europe at Samsung Bioepis. He emphasized the importance of collaborating
A smartphone with a stethoscope, representing virtual healthcare services.

May 29, 2026

Teladoc Health Partners With Walmart to Expand Virtual Care Services Across U.S.

Teladoc Health has joined forces with Walmart to enhance access to virtual healthcare services nationwide, integrating various medical offerings into Walmart's Better Care Services platform.This partnership enables Walmart customers to utilize Teladoc's virtual care services, either through insurance or cash-pay options. For a fee of $89, users can engage in virtual consultations for common ailments like sinus infections and flu-like symptoms. Additionally, dermatology services allow patients to
A minimalist illustration of a chip and a mineral crystal on a dark background.

May 29, 2026

India-US trade deal likely in coming weeks or months; AI, chips, pharma, critical minerals among key focus areas: US Ambassador

India and the United States are nearing the completion of a significant interim trade agreement, anticipated to be finalized within weeks or months. This development comes as both nations enhance their economic collaboration, particularly in sectors such as artificial intelligence, semiconductors, and pharmaceuticals.During a recent event at the Indian Institute of Technology in Delhi, US Ambassador to India, Sergio Gor, indicated that negotiations are in their final stages. He mentioned that a
A stock market ticker on a trading floor during blue hour

May 29, 2026

Infosys Closing Bell Updates: Stock Posts Marginal Gain on AI Partnership

Infosys has experienced a day of mixed trading, closing slightly higher following an announcement of a significant AI partnership.On May 29, 2026, Infosys (NSE: INFY) opened at ₹1,182.00 but finished the day at ₹1,160.90, marking a modest increase of 0.09%. The stock exhibited notable intraday volatility, reaching a high of ₹1,210.00 and a low of ₹1,153.60, with trading volumes significantly surpassing daily averages at over 69 million shares. This activity reflects a strong investor interest, a
Flat design illustration of lung and breast cancer cells

May 29, 2026

AstraZeneca & Roche Push AI-Based Cancer Pathology Expansion Across Asia

AstraZeneca and Roche Diagnostics Asia Pacific have embarked on a significant collaboration aimed at enhancing AI-driven cancer pathology across multiple Asian countries. This three-year initiative will specifically target Singapore, Taiwan, South Korea, Thailand, Malaysia, India, Indonesia, Vietnam, and the Philippines.The partnership seeks to advance biomarker testing and facilitate more precise treatment options for patients with breast and lung cancer. AstraZeneca and Roche plan to implement
A medical chart and stethoscope in a clinical setting

May 29, 2026

Britain and France strike landmark AI pact to transform women's health and tackle drug-resistant superbugs

A new partnership between Britain and France aims to enhance women's health and combat drug-resistant infections through the integration of artificial intelligence and shared clinical data. Announced during G7 discussions, this collaboration seeks to address longstanding issues in under-researched areas such as endometriosis and infectious diseases, providing a framework for joint research and development.The partnership is set to accelerate advancements in women's health, where many conditions
A stack of clinical trial documents on a conference table with a whiteboard in the background.

May 29, 2026

Half of clinical trial professionals cite trust and regulatory gaps as barrier to AI adoption, Pistoia Alliance poll finds

A recent poll conducted by the Pistoia Alliance highlights significant barriers to AI adoption in clinical trials, with trust and regulatory uncertainty being the primary concerns for 50% of respondents. This survey was part of the Clinical Trials Technology Congress in London, where discussions centered on how regulators are prepared to collaborate with pharmaceutical companies to ensure the safe and compliant integration of AI technologies.At the Congress, regulators from various agencies expr
A minimalist illustration of a calculator and a coin representing finance support.

May 29, 2026

NHS SBS and Salesforce launch AI finance support platform

NHS Shared Business Services (NHS SBS) has collaborated with Salesforce to introduce an innovative AI-driven digital help center aimed at enhancing finance and procurement support throughout the NHS.This new platform, named SBS One, is a key component of NHS SBS's broader strategy to modernize its finance and procurement services. Utilizing Salesforce’s Agentforce 360 for Public Sector, it integrates self-service tools, automation, and AI agents to assist NHS staff and suppliers with various que
A minimalist heart silhouette with an ECG line, representing AI in diagnostics.

May 29, 2026

Artificial Intelligence in Diagnostics Market to Surpass US$ 6.52 Billion by 2033 as AI Revolutionizes Global Healthcare

The artificial intelligence (AI) diagnostics market is poised for significant growth, projected to reach over $6.52 billion by 2033, driven by advancements in technology and increasing demand for early disease detection.AI is transforming healthcare diagnostics by enabling quicker and more accurate disease detection, which is crucial in fields like oncology, cardiology, and radiology. As healthcare systems face pressure to improve diagnostic accuracy and efficiency, AI technologies are increasin
A retinal imaging device in a clinical setting, highlighting the focus on diabetic retinopathy screening.

May 29, 2026

AI-Driven Diabetic Retinopathy Screening Market is expected

The AI-driven diabetic retinopathy screening market is projected to experience significant growth, reaching an estimated value of $2.22 billion by 2033. This growth is fueled by a compound annual growth rate (CAGR) of 21% from 2026 to 2033, as the industry increasingly adopts AI technologies for early disease detection and diagnosis.The market encompasses various AI-based solutions that enhance the detection and diagnosis of diabetic retinopathy through advanced retinal imaging and automated ana
CT scanner in a dimly lit radiology room

May 29, 2026

AI-Powered Diagnostic Imaging Market Size, Share & Industry

The AI-powered diagnostic imaging market is on a significant growth trajectory, projected to reach USD 22.58 billion by 2032, expanding at a compound annual growth rate (CAGR) of 26.40% from 2026 to 2032.This expansion is fueled by a surge in demand for AI-assisted disease detection, advancements in imaging technologies, and increased investments in precision diagnostics. The integration of machine learning and computer vision into radiology is enhancing diagnostic accuracy and addressing the sh
A minimalist illustration of a clinical trial participant's arm with a blood drop, set against a dark background.

May 29, 2026

AI’s next pharma challenge: tackling costly and risky clinical trials

AI is poised to revolutionize the clinical trial landscape, addressing long-standing inefficiencies and high costs associated with drug testing.Pharmaceutical companies have long faced significant challenges in clinical trials, with the average drug development process taking over a decade and costing between $1-2 billion. A staggering 90% of drugs fail during human testing, leading to wasted resources and delayed patient access. However, advancements in artificial intelligence (AI) are emerging